Skip to content

SPG Neurostimulation in Cluster Patients

Sphenopalataine Ganglion (SPG) Stimulation in Cluster Headache Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02510729
Enrollment
21
Registered
2015-07-29
Start date
2015-07-31
Completion date
2016-10-31
Last updated
2017-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Cluster Headache

Brief summary

We hypothesized that LF stimulation of the SPG would increase parasympathetic outflow, activate sensory afferents and provoke a cluster-like attack.

Detailed description

We conducted a double-blind, randomized, sham-controlled, crossover study to investigate cluster attack induction following LF (20 Hz and 0.2-2.1 amplitude) and sham (amplitude = 0) stimulation in 20 CH patients with implanted SPG neurostimulator. In addition, we measured plasma concentrations of pituitary adenylate cyclase-activating polypeptide-38 (PACAP38) and vasoactive intestinal peptide (VIP), as markers for parasympathetic activation before, during and after SPG stimulation. We also investigated if LF SPG stimulation induces changes in cardiac autonomic regulation and whether any attacks induced by SPG stimulation are associated with such changes.

Interventions

DEVICESham stimulation

Sponsors

Danish Headache Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Chronic cluster patients

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Incidence of cluster-like attacks and cephalic autonomic symptoms0-60 minDifference in incidence of cluster-like attacks and cephalic autonomic symptoms between LF and sham stimulation.

Secondary

MeasureTime frameDescription
Mechanical detection and pain thresholds0-60 minDifference in mechanical detection and pain thresholds in the face between LF and sham stimulation measured by pin-prick and von Frey hairs.
Plasma concentrations of PACAP38 and VIP0-60 minDifference in plasma concentrations of PACAP38 and VIP between LF and sham stimulation.
Cardiac autonomic regulation (HRV)0-60 minChanges in cardiac autonomic regulation (HRV) between LF and sham stimulation and during cluster attacks measured by continious ECG.
Mean arterial blood pressure and heart rate0-60 minDifference in mean arterial blood pressure and heart rate between LF and sham stimulation.
Headache intensity0-60 minDifference in headache intensity measured by numerical rating scale (NRS 0-10) between LF and sham stimulation.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026